Publications

Found 1 results
Filters: Author is Z.G. Zhang  [Clear All Filters]
2011
H. Y. Jia, Zhang, Z. G., Gu, X. J., Guo, T., Cui, B., Ning, G., and Zhao, Y. J., Association between interleukin 21 and Graves’ disease, vol. 10, pp. 3338-3346, 2011.
Bahn RS (1995). Assessment and management of the patient with Graves' ophthalmopathy. Endocr. Pract. 1: 172-178. PMid:15251590   Ban Y and Tomer Y (2003). The contribution of immune regulatory and thyroid specific genes to the etiology of Graves' and Hashimoto's diseases. Autoimmunity 36: 367-379. http://dx.doi.org/10.1080/08916930310001603037 PMid:14669944   Barrett JC, Fry B, Maller J and Daly MJ (2005). Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265. http://dx.doi.org/10.1093/bioinformatics/bth457 PMid:15297300   Bednarczuk T, Gopinath B, Ploski R and Wall JR (2007). Susceptibility genes in Graves' ophthalmopathy: searching for a needle in a haystack? Clin. Endocrinol. 67: 3-19. http://dx.doi.org/10.1111/j.1365-2265.2007.02854.x PMid:17521325   Caprioli F, Sarra M, Caruso R, Stolfi C, et al. (2008). Autocrine regulation of IL-21 production in human T lymphocytes. J. Immunol. 180: 1800-1807. PMid:18209077   Caruso R, Fina D, Peluso I, Fantini MC, et al. (2007). IL-21 is highly produced in Helicobacter pylori-infected gastric mucosa and promotes gelatinases synthesis. J. Immunol. 178: 5957-5965. PMid:17442980   Chen RH, Chen WC, Chang CT, Tsai CH, et al. (2005). Interleukin-1-beta gene, but not the interleukin-1 receptor antagonist gene, is associated with Graves' disease. J. Clin. Lab. Anal. 19: 133-138. http://dx.doi.org/10.1002/jcla.20067 PMid:16025481   Davis ID, Skak K, Smyth MJ, Kristjansen PE, et al. (2007). Interleukin-21 signaling: functions in cancer and autoimmunity. Clin. Cancer Res. 13: 6926-6932. http://dx.doi.org/10.1158/1078-0432.CCR-07-1238 PMid:18056166   Farid NR and Balazs C (1998). The genetics of thyroid associated ophthalmopathy. Thyroid 8: 407-409. http://dx.doi.org/10.1089/thy.1998.8.407 PMid:9623731   Hiromatsu Y, Kaku H, Miyake I, Murayama S, et al. (2002). Role of cytokines in the pathogenesis of thyroid-associated ophthalmopathy. Thyroid 12: 217-221. http://dx.doi.org/10.1089/105072502753600160 PMid:11952042   Hiromatsu Y, Mukai T, Kaku H, Miyake I, et al. (2006). IL-18 gene polymorphism confers susceptibility to the development of anti-GAD65 antibody in Graves' disease. Diabet. Med. 23: 211-215. http://dx.doi.org/10.1111/j.1464-5491.2005.01734.x PMid:16433722   Kasaian MT, Whitters MJ, Carter LL, Lowe LD, et al. (2002). IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity. Immunity 16: 559-569. http://dx.doi.org/10.1016/S1074-7613(02)00295-9   Leonard WJ and Spolski R (2005). Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation. Nat. Rev. Immunol. 5: 688-698. http://dx.doi.org/10.1038/nri1688 PMid:16138102   Liang J, Chen P, Hu Z, Zhou X, et al. (2008). Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women. Carcinogenesis 29: 2341-2346. http://dx.doi.org/10.1093/carcin/bgn235 PMid:18845558   Lin MC, Hsu FM, Bee YS and Ger LP (2008). Age influences the severity of Graves' ophthalmopathy. Kaohsiung J. Med. Sci. 24: 283-288. http://dx.doi.org/10.1016/S1607-551X(08)70154-2   Liu R, Van KL, La CA, Price M, et al. (2006). Autoreactive T cells mediate NK cell degeneration in autoimmune disease. J. Immunol. 176: 5247-5254. PMid:16621990   Liu Y, Helms C, Liao W, Zaba LC, et al. (2008). A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet. 4: e1000041. http://dx.doi.org/10.1371/journal.pgen.1000041 PMid:18369459 PMCid:2274885   Mehta DS, Wurster AL and Grusby MJ (2004). Biology of IL-21 and the IL-21 receptor. Immunol. Rev. 202: 84-95. http://dx.doi.org/10.1111/j.0105-2896.2004.00201.x PMid:15546387   Meller J, Jauho A, Hufner M, Gratz S, et al. (2000). Disseminated thyroid autonomy or Graves' disease: reevaluation by a second generation TSH receptor antibody assay. Thyroid 10: 1073-1079. http://dx.doi.org/10.1089/thy.2000.10.1073 PMid:11201852   Mourits MP, Koornneef L, Wiersinga WM, Prummel MF, et al. (1989). Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. Br. J. Ophthalmol. 73: 639-644. http://dx.doi.org/10.1136/bjo.73.8.639 PMid:2765444 PMCid:1041835   Ozaki K, Spolski R, Feng CG, Qi CF, et al. (2002). A critical role for IL-21 in regulating immunoglobulin production. Science 298: 1630-1634. http://dx.doi.org/10.1126/science.1077002 PMid:12446913   Parrish-Novak J, Dillon SR, Nelson A, Hammond A, et al. (2000). Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408: 57-63. http://dx.doi.org/10.1038/35040504 PMid:11081504   Piao WH, Jee YH, Liu RL, Coons SW, et al. (2008). IL-21 modulates CD4+ CD25+ regulatory T-cell homeostasis in experimental autoimmune encephalomyelitis. Scand. J. Immunol. 67: 37-46. http://dx.doi.org/10.1111/j.1365-3083.2007.02035.x PMid:18052963   Solé X, Guinó E, Valls J, Iniesta R, et al. (2006). SNPStats: a web tool for the analysis of association studies. Bioinformatics 22: 1928-1929. http://dx.doi.org/10.1093/bioinformatics/btl268 PMid:16720584   Spolski R and Leonard WJ (2008a). Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu. Rev. Immunol. 26: 57-79. http://dx.doi.org/10.1146/annurev.immunol.26.021607.090316 PMid:17953510   Spolski R and Leonard WJ (2008b). The Yin and Yang of interleukin-21 in allergy, autoimmunity and cancer. Curr. Opin. Immunol. 20: 295-301. http://dx.doi.org/10.1016/j.coi.2008.02.004 PMid:18554883 PMCid:2546604   Strengell M, Matikainen S, Siren J, Lehtonen A, et al. (2003). IL-21 in synergy with IL-15 or IL-18 enhances IFN-gamma production in human NK and T cells. J. Immunol. 170: 5464-5469. PMid:12759422   Vollmer TL, Liu R, Price M, Rhodes S, et al. (2005). Differential effects of IL-21 during initiation and progression of autoimmunity against neuroantigen. J. Immunol. 174: 2696-2701. PMid:15728477   Wall JR, Salvi M, Bernard NF, Boucher A, et al. (1991). Thyroid-associated ophthalmopathy - a model for the association of organ-specific autoimmune disorders. Immunol. Today 12: 150-153. PMid:1878126   Weetman AP, Cohen S, Gatter KC, Fells P, et al. (1989). Immunohistochemical analysis of the retrobulbar tissues in Graves' ophthalmopathy. Clin. Exp. Immunol. 75: 222-227. PMid:2784734 PMCid:1542121   Yamada M, Li AW and Wall JR (2000). Thyroid-associated ophthalmopathy: clinical features, pathogenesis, and management. Crit. Rev. Clin. Lab. Sci. 37: 523-549. http://dx.doi.org/10.1080/10408360091174303 PMid:11192331